In comparison to LD tumours, LI tumours were significantly enriched for left-sided tumours (sigmoid and rectum), KRAS mutations and CMS2 (canonical) classification, consistent with conventional lesion molecular pathway (figure 5A, B, online supplementary table 9). The gene discussed is KRAS; the disease is neoplasm.